$CRBU has been discussed by 2 distinct FinTwit voices over a 10-hour period on November 3, 2025, generating 15 mentions total. @jacobplieth (@jacobplieth) is the most active voice with 11 mentions, while @adamfeuerstein (@adamfeuerstein) contributed 4 mentions. The discussion centers on Caribou Biosciences' clinical trial design and methodologies, with @jacobplieth raising questions about the company's phase 3 formula specifications and HLA allele matching approaches.